The effect of FK 506 on regeneration of the liver was studied in rats after a two-thirds partial hepatectomy after 60 min of ischemia of the unresected liver. The animals were divided into three distinct groups of 10 rats each. Group 1 (controls) received 0.5 ml saline solution intravenously 30 min after the induction of ischemia. Groups 2 and 3 were injected with FK 506 (0.3 mg/kg) intravenously 30 min after and 24 min before the induction of hepatic ischemia, respectively. The hepatic content of ATP and serum levels of ALT and lactate dehydrogenase were determined on each animal. In addition, the histological appearance and mitotic activity of the remnant liver was determined at regular 24-hr intervals after hepatic ischemia. All 10 control animals died within 72 hr. Treatment with FK 506 resulted in improved survival in groups 2 and 3 (30% and 80%, respectively). The improved survival seen in the FK 506-treated animals was reflected by a restoration of hepatic ATP content, a reduction in the serum levels of ALT and lactate dehydrogenase, an amelioration of hepatic necrosis and neutrophilic infiltration and an increase in the mitotic activity of the liver. These results suggest that FK 506 ameliorates the hepatic injury associated with ischemia/ reperfusion and has a potent stimulatory effect on liver cell regeneration that may make it valuable as a hepatoprotective agent when administered to organ donors before graft harvesting.In recent years, orthotopic liver transplantation (OLT) has been accepted as a reasonable therapy for patients with end-stage liver disease (1). However, the allograft liver is subject to a variety of insults as a result of ischemia experienced during the organ harvest, reperfusion at the time of organ engraftment, and eventually as part of the recipient's immunological response to the allograft after transplantation. The ability of the liver to withstand these injuries and then to regenerate and regulate its ultimate size is crucial after clinical liver transplantation.Recently, it has been reported that FK 506 (FK), in addition to being a powerful immunosuppressive agent, is also hepatotrophic agent (2,3). To further clarify this issue, this study was performed. Specifically the efficacy of FK in protecting the liver against the injury associated with ischemia/reperfusion in rats subjected to a two-thirds hepatectomy after 60-min of ischemia was examined.
MATERIALS AND METHODS
Surgical ProcedureAdult male Lewis rats weighing between 200 and 300 gm were used in the study. Anesthesia was induced using ether and was maintained with inhalation of metofane. Through a midline abdominal incision a 60-min period of ischemia of the right lateral lobe of the liver was induced by placing noncrushing microvascular clamps around the appropriate branches of the portal vein and hepatic artery using an operative microscope. On releasing the clamps and restoring blood flow to the right lateral lobe, the median and left lateral lobes of the liver were excised according to the method of Higgin...